ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 995

Rheumatoid Arthritis Patients Have Alterations in Inherently Autoreactive 9G4+ B-Cell Subpopulations in Peripheral Blood

Rita A. Moura1,2, Maria J. Leandro3, Venkat Reddy1, João E. Fonseca2,4 and Geraldine Cambridge3, 1Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, 2Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, 3Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom, 4Rheumatology Department, Centro Hospitalar de Lisboa Norte, EPE, Hospital de Santa Maria, Lisbon, Portugal

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Autoimmunity, B cells, immunology and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Biology and Targets in Autoimmune Disease: Rheumatoid Arthritis and Related Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose B-cells utilizing the VH-region immunoglobulin gene VH4-34 produce natural autoreactive antibodies. The rat monoclonal antibody 9G4 recognizes B-cells with VH4-34-encoded B-cell receptors (9G4+ B-cells) and also secreted immunoglobulins. In healthy individuals, 9G4+ B-cells present in splenic marginal zones and tonsils are excluded from germinal centre (GC) reactions, whereas in autoimmune diseases such as systemic lupus erythematosus, 9G4+ B-cells expand in the post-GC memory compartment, suggesting defective 9G4+ B-cell censoring mechanisms. In rheumatoid arthritis (RA) patients, the distribution of tonsil 9G4+ B-cells is similar to healthy individuals, but only limited phenotypic analyses have examined 9G4+ B-cells in peripheral blood. The aim of this work was to perform an extensive phenotype characterization of 9G4+ B-cell sub-populations in peripheral blood in RA patients and healthy controls (HC).

Methods Blood samples were collected from established RA patients (n=12) and age and sex-matched HC (n=15). Peripheral blood mononuclear cells were isolated by density gradient centrifugation and 9G4+ B-cells (gated in CD19+ B-cells) were characterized by flow cytometry. 9G4+ B-cell subpopulations were defined using combinations of IgD, CD27 and CD38. The expression of CD5, CD24, IgM, BAFF-R and CXCR5 was analyzed in total 9G4+ B-cells. Statistical analysis was performed with Mann-Whitney test. 

Results The frequency of total 9G4+ B-cells in circulation was similar between RA patients and HC (median values: 3.83% and 4.68%, respectively). We found that RA patients had a higher frequency of 9G4+IgD-CD27- B-cells than HC (p=0.04). No significant differences were found in other 9G4+ subpopulations based on IgD/CD27 classification, although there was a tendency for higher levels of 9G4+ switched memory B-cells (IgD-CD27+). RA patients also had significantly lower levels of 9G4+ transitional B-cells (IgD+CD38+++) (p=0.004) and 9G4+ plasmablasts (IgD-CD27+++CD38+++) (p=0.004) and increased frequencies of 9G4+ naïve B-cells (IgD+38++) (p=0.04) when compared to HC. A tendency for higher levels of 9G4+ post-GC memory B-cells (IgD-CD38+) was also observed in RA patients. Furthermore, BAFF-R expression was significantly increased in 9G4+ B-cells from RA patients (both frequency and mean fluorescence intensity values) compared to HC (p=0.04 and p=0.006, respectively). There was a significant decrease in levels of 9G4+CD5+ B-cells (p=0.004) in RA patients, but no other significant differences were found in 9G4+ B-cells expressing CD24, IgM and CXCR5.

Conclusion RA patients have alterations in the frequency of 9G4+ B-cell subpopulations when compared to healthy individuals. The significant reduction in the frequency of 9G4+ transitional and 9G4+CD5+B-cells and the increased levels of 9G4+ naïve B-cells suggests a more rapid maturation of 9G4+ B-cells in RA patients following entry into the peripheral pool. This could be influenced by the antigen specificity of the B-cell receptor. Furthermore, the increased BAFF-R expression by 9G4+ B-cells observed in RA patients might support an increased survival mechanism for these already inherently autoreactive B-cells.


Disclosure:

R. A. Moura,
None;

M. J. Leandro,
None;

V. Reddy,
None;

J. E. Fonseca,
None;

G. Cambridge,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-have-alterations-in-inherently-autoreactive-9g4-b-cell-subpopulations-in-peripheral-blood/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology